Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (381-390 of 574) with videos related to

Pageof 58
Sort By:
Journal of Obsessive-Compulsive and Related Disorders|December 2, 2014
Progress in research on Tourette syndromeKevin J Black, Joseph Jankovic, Tamara Hershey, et al.
Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Parkinsonism & Related Disorders|February 15, 2011
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulationAmy E Williams, Gladys Marina Arzola, Adriana M Strutt, et al.
Movement Disorders Clinical Practice|August 27, 2024
Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta-AnalysisLuis Guilherme Ramanzini, Julia M Frare, Luís F M Camargo, et al.
Pharmacological Research|May 9, 2025
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challengesZhi Dong Zhou, Lingxiao Yi, Karolina Popławska-Domaszewicz, et al.
Journal of Neurochemistry|April 11, 2008
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degenerationWen Zhu, Wenjie Xie, Tianhong Pan, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disordersMark Hallett, Alberto Albanese, Dirk Dressler, et al.
Parkinsonism & Related Disorders|May 17, 2011
Essential tremor quantification during activities of daily livingDustin A Heldman, Joseph Jankovic, David E Vaillancourt, et al.
Nature Reviews. Disease Primers|November 12, 2021
Essential tremorThomas Welton, Francisco Cardoso, Jonathan A Carr, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scaleGlenn T Stebbins, Christopher G Goetz, David J Burn, et al.
Pageof 58

Showing results (381-390 of 574) with videos related to

Sort By:
Pageof 58
Journal of Obsessive-Compulsive and Related Disorders|December 2, 2014
Progress in research on Tourette syndromeKevin J Black, Joseph Jankovic, Tamara Hershey, et al.
Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Parkinsonism & Related Disorders|February 15, 2011
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulationAmy E Williams, Gladys Marina Arzola, Adriana M Strutt, et al.
Movement Disorders Clinical Practice|August 27, 2024
Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta-AnalysisLuis Guilherme Ramanzini, Julia M Frare, Luís F M Camargo, et al.
Pharmacological Research|May 9, 2025
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challengesZhi Dong Zhou, Lingxiao Yi, Karolina Popławska-Domaszewicz, et al.
Journal of Neurochemistry|April 11, 2008
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degenerationWen Zhu, Wenjie Xie, Tianhong Pan, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disordersMark Hallett, Alberto Albanese, Dirk Dressler, et al.
Parkinsonism & Related Disorders|May 17, 2011
Essential tremor quantification during activities of daily livingDustin A Heldman, Joseph Jankovic, David E Vaillancourt, et al.
Nature Reviews. Disease Primers|November 12, 2021
Essential tremorThomas Welton, Francisco Cardoso, Jonathan A Carr, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scaleGlenn T Stebbins, Christopher G Goetz, David J Burn, et al.
Pageof 58